Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Biomarker and diagnostic research for encephalopathy, progressive, early-onset, with brain edema and/or leukoencephalopathy has been reported in the published literature.
No clinical trials have been registered for encephalopathy, progressive, early-onset, with brain edema and/or leukoencephalopathy.
203 publications have been identified in PubMed for encephalopathy, progressive, early-onset, with brain edema and/or leukoencephalopathy. Research spans Basic Science / Preclinical (28%), Case Report / Case Series (25%), and Review / Meta-Analysis (20%).
Research Type | Count | % of Total |
|---|---|---|
Laboratory research | 52 | 28% |
Data assembled from 2 of 12 sources · Last updated Sep 20, 2026, 11:40 AM UTC
Patient case studies | 46 | 25% |
Research summaries | 36 | 20% |
Disease patterns and progression | 18 | 10% |
Testing and diagnosis research | 13 | 7% |
New treatment approaches | 11 | 6% |
Clinical study results | 7 | 4% |
Other research | 1 | 1% |
Bisseling Q (2026). [PMID: 41331492](https://pubmed.ncbi.nlm.nih.gov/41331492/). *Glia*. [Gene Therapy / Novel Therapeutics]
Çöpür S (2026). [PMID: 41615015](https://pubmed.ncbi.nlm.nih.gov/41615015/). *Mod Rheumatol Case Rep*. [Case Report / Case Series]
Macaron G (2026). [PMID: 41925503](https://pubmed.ncbi.nlm.nih.gov/41925503/). *Continuum (Minneap Minn)*. [Review / Meta-Analysis]
Flanagan EP (2026). [PMID: 41925507](https://pubmed.ncbi.nlm.nih.gov/41925507/). *Continuum (Minneap Minn)*. [Review / Meta-Analysis]
Santiago IB (2026). [PMID: 41638970](https://pubmed.ncbi.nlm.nih.gov/41638970/). *Rev Neurol (Paris)*. [Review / Meta-Analysis]
Garofolo I (2026). [PMID: 40948401](https://pubmed.ncbi.nlm.nih.gov/40948401/). *Ann Neurol*. [Gene Therapy / Novel Therapeutics]
Balcerac A (2026). [PMID: 41644378](https://pubmed.ncbi.nlm.nih.gov/41644378/). *Rev Neurol (Paris)*. [Clinical Trial Publication]
Wagstaff H (2026). [PMID: 41260848](https://pubmed.ncbi.nlm.nih.gov/41260848/). *Emerg Med Clin North Am*. [Review / Meta-Analysis]
Miura Y (2026). [PMID: 42156040](https://pubmed.ncbi.nlm.nih.gov/42156040/). *Brain Nerve*. [Review / Meta-Analysis]
Wijdicks EFM (2026). [PMID: 41631914](https://pubmed.ncbi.nlm.nih.gov/41631914/). *Continuum (Minneap Minn)*. [Review / Meta-Analysis]